Chardan Capital Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $40
9/18/2026
Impact: 75
Healthcare
Chardan Capital analyst Andreas Argyrides has initiated coverage on Agenus (NASDAQ: AGEN) with a Buy rating. The firm has set a price target of $40 for the stock.
AI summary, not financial advice
Share: